2007 Immunization Vaccines 
Pharmaceutical Technology
AUGUST 8, 2025
Using real-world data to support vaccine outreach and education Buy Reports Newsletters PT News EpiPen patent expiry opens new era for innovation The expiration of Viatris’s EpiPen patent in September 2025 will likely result in increased competition and lower costs in the epinephrine delivery space.
PharmTech
AUGUST 11, 2025
Needle of a syringe protrudes through the rubber cap of a vaccine vial with red cap. Some PFAS chemicals have been proven to cause diseases such as cancer, liver damage, hormone disruption, and weakening of the immune system (7). OECD Environment Directorate. Chemicals and Biotechnology Committee. 2018 (accessed October 2023).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JUNE 25, 2025
In a new CDC report, investigators found that there was no connection between thimerosal in vaccines and autism or other neurodevelopmental conditions. The properties of thimerosal were documented to contribute to the safe use of multidose vials and packaging of vaccines, such as seasonal and pandemic influenza vaccines.
Pharmacy Times
JULY 29, 2025
A frequently cited example is the 1881 anthrax vaccine demonstration at Pouilly-le-Fort, which Pasteur publicly described as a success resulting from oxygen attenuation techniques. However, his private notebooks reveal a more complex process characterized by trial and error, methodological changes, and episodes of uncertainty.
European Pharmaceutical Review
DECEMBER 12, 2023
He discusses why NK cell therapy’s ability to generate ‘synthetic immunity’ in the body means this modality holds potential as an anti-cancer treatment. We specialise in the development of new cutting-edge immunotherapies , based on the use of therapeutic antibodies capable of activating the immune system to fight cancer.
The People's Pharmacy
MAY 29, 2023
The virus hides for decades and when the immune system is no longer able to keep it at bay the virus can cause an extremely painful skin rash that can last for weeks. When the immune system weakens, the virus can be reactivated and cause a rash. That is to say it can enhance the immune systems ability to fight off certain viruses.
pharmaphorum
OCTOBER 12, 2022
Del Bourgo highlights that genomic treatments work in a similar way to mRNA, which has been used in COVID-19 vaccines. Similar to how we injected mRNA into people to trigger an immune response and train their immune system against COVID-19, genomic medicine repairs cellular or molecular mechanisms that are dysfunctional and cause disease.”.
Expert insights. Personalized for you.
Let's personalize your content